What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 2023 Daniela Godinho, Marta Freixa, Filipe Froes

Pneumocystosis pneumonia in immunocompromised patients Beuy Joob, Viroj Wiwanitkit

Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations S. Oldani, C. Ravaglia, S. Bensai, L. Bertolovic, C. Ghirotti, S. Puglisi, S. Martinello, F. Sultani, C. Colinelli, S. Piciucchi, S. Simoncelli, V. Poletti